The GLP-1 analogue liraglutide decreases the pro-inflammatory status of the heart in diabetes

被引：0
|
作者：
Emmens, R. W. [1 ]
Baylan, U. [1 ]
Naaijkens, B. [1 ]
Schalkwijk, C. G. [2 ]
Niessen, H. W. M. [1 ]
Krijnen, P. A. J. [1 ]
Simsek, S. [3 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Maastricht Univ, CARIM, Dept Internal Med, Maastricht, Netherlands
[3] Med Ctr Alkmaar, Alkmaar, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：329 / 330
页数：2
相关论文
共 50 条
  • [31] Projecting the long-term clinical benefits of treatment with the GLP-1 analogue liraglutide in subjects with type 2 diabetes
    Valentine, William J.
    Hammer, Mette
    Palmer, Andrew J.
    Ray, Joshua A.
    DIABETES, 2007, 56 : A568 - A568
  • [32] GLP-1 analogue shown to protect against heart failure
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2013, 15 (05): : 482 - 482
  • [33] Acute Metabolic Effects of GLP-1 Analogue in Type 1 Diabetes
    Ghazi, Tara
    Rink, Linda
    Sherr, Jennifer L.
    Herold, Kevan C.
    DIABETES, 2013, 62 : A264 - A264
  • [34] Counselling Patients for GLP-1 Analogue Therapy: Comparing GLP-1 Analogue with Insulin Counselling
    Kalra, Sanjay
    Kalra, Bharti
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2012, 4 (12) : 638 - 640
  • [35] Acute peripheral administration of synthetic human GLP-1 (7-36 amide) decreases circulating IL-6 in obese patients with type 2 diabetes mellitus: A potential role for GLP-1 in modulation of the diabetic pro-inflammatory state?
    Daousi, Christina
    Pinkney, Jonathan H.
    Cleator, Jacqueline
    Wilding, John P.
    Ranganath, L. R.
    REGULATORY PEPTIDES, 2013, 183 : 54 - 61
  • [36] Type 2 Diabetes: GLP-1-Analogue Effective Liraglutide as Glimepirid
    Menge, Bjoern
    Meier, Juris J.
    DIABETOLOGIE UND STOFFWECHSEL, 2009, 4 (02) : 95 - 95
  • [37] The GLP-1 Receptor Agonist Liraglutide Improves Autophagy Impairment in the Diabetic Heart
    Bugyei-Twum, Antoinette
    Switzer, Jennifer
    Singh, Krishna K.
    Connelly, Kim A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [38] Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
    Lin, Chia-Hung
    Lee, Yun-Shien
    Huang, Yu-Yao
    Hsieh, Sheng-Hwu
    Chen, Zih-Syuan
    Tsai, Chi-Neu
    JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [39] The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
    Crane, James
    McGowan, Barbara
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (02) : 92 - 107
  • [40] A COMPARISON OF THE EFFECTS OF THE GLP-1 ANALOGUE LIRAGLUTIDE AND INSULIN GLARGINE ON METABOLIC PARAMETERS AND ENDOTHELIAL FUNCTION
    Nomoto, H.
    Miyoshi, H.
    Nakamura, A.
    Manda, N.
    Kurihara, Y.
    Atsumi, T.
    Aoki, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S59 - S59
12345